J
James S. Goodwin
Researcher at University of Texas Medical Branch
Publications - 567
Citations - 36690
James S. Goodwin is an academic researcher from University of Texas Medical Branch. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 97, co-authored 556 publications receiving 34455 citations. Previous affiliations of James S. Goodwin include New York University & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Resection Benefits Older Adults with Locoregional Pancreatic Cancer Despite Greater Short-Term Morbidity and Mortality
TL;DR: Evaluated time trends in surgical resection rates and operative mortality in older adults diagnosed with locoregional pancreatic cancer and the effect of age on surgical resections rates and 2‐year survival after surgery are evaluated.
Journal ArticleDOI
Overuse of Preoperative Cardiac Stress Testing in Medicare Patients Undergoing Elective Noncardiac Surgery
Kristin M. Sheffield,Patricia S. McAdams,Jaime Benarroch-Gampel,James S. Goodwin,Casey A. Boyd,Dong Zhang,Taylor S. Riall +6 more
TL;DR: It is estimated that there are over 56,000 patients who underwent unnecessary preoperative stress testing in Medicare patients with no indications for cardiovascular evaluation who should not undergo cardiac stress testing before elective noncardiac, nonvascular surgery.
Journal ArticleDOI
Anti-Ia Reactivity in Sera from Patients with Systemic Lupus Erythematosus
TL;DR: Results indicated that antibodies in SLE sera react with structures contiguous to or identical with Ia determinants, and there was a significant negative correlation between anti-Ia blocking activity in the sera and the percentage of Ia-positive T cells in the blood of SLE patients.
Journal ArticleDOI
Decline in opioid prescribing after federal rescheduling of hydrocodone products.
TL;DR: To examine differences in opioid prescribing by patient characteristics and variation in hydrocodone combination product (HCP) prescribing attributed to states, before and after the 2014 Drug Enforcement Administration's reclassification of HCP from schedule III to the more restrictive schedule II.
Journal ArticleDOI
Geriatrics and the limits of modern medicine
TL;DR: Like a number of geriatricians, I have come to believe that modern medicine does not work well for old people.